Source: Annual Congress 2006 - Clinical features of sarcoidosis and other granolomatous disorders
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Cilt, D. Ionita, I. P. Stoicescu (Bucharest, Romania). Late onset sarcoidosis. Eur Respir J 2006; 28: Suppl. 50, 3111

Member's Comments

No comment yet.

Related content which might interest you: Late onset asthma: A distinct phenotype Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Late stage diagnosis in a case of Hodgkin disease with nodular sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 90s Year: 2006 Early diagnosis of extrapulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 543s Year: 2006 Adult onset Still‘s disease with pleuropericarditis Source: Eur Respir J 2007; 30: Suppl. 51, 569s Year: 2007 Early and late onset asthma: are they the same? Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Late onset Pompe Disease: A rare cause of respiratory failure Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Respiratory problems in late onset Pompe disease Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Manifestations of malignancies during the course of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Changed phenotype and worsening of the course in sarcoidosis over time Source: Eur Respir J 2007; 30: Suppl. 51, 85s Year: 2007 Timing of cardiac sarcoidosis in patients with sarcoidosis> Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Occult malignancy underlying a case of “hyperacute” onset of severe pulmonary hypertension Source: ERJ Open Res, 5 (4) 00157-2019; 10.1183/23120541.00157-2019 Year: 2019 Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical features of sarcoidosis patients with erythema nodosum and predictors of the course at onset: a single center experience from Turkey Source: Eur Respir J 2007; 30: Suppl. 51, 84s Year: 2007 Destructive bronchiolitis: a characteristic pathological feature of interstitial lung disease preceding the onset of rheumatoid arthritis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Incidence of coeliac disease in patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001 Relationship between clinical symptoms and severity of alveolitis in patients with new-onset sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002 Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Fatal acute exacerbation of idiopathic pulmonary fibrosis: report of 4 cases Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007